RT Journal Article
SR Electronic
T1 Randomized Trial of Ketamine Masked by Surgical Anesthesia in Depressed Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.28.23289210
DO 10.1101/2023.04.28.23289210
A1 Lii, Theresa R.
A1 Smith, Ashleigh E.
A1 Flohr, Josephine R.
A1 Okada, Robin L.
A1 Nyongesa, Cynthia A.
A1 Cianfichi, Lisa J.
A1 Hack, Laura M.
A1 Schatzberg, Alan F.
A1 Heifets, Boris D.
YR 2023
UL http://medrxiv.org/content/early/2023/06/15/2023.04.28.23289210.abstract
AB BACKGROUND Ketamine may have antidepressant properties, but its acute psychoactive effects complicate successful masking in placebo-controlled trials.METHODS In a triple-masked, randomized, placebo-controlled trial, 40 adult patients with major depressive disorder were randomized to a single infusion of ketamine (0.5 mg/kg) or placebo (saline) during anesthesia as usual for routine surgery. The primary outcome was depression severity measured by the Montgomery-Åsberg Depression Rating Scale (MADRS) at 1, 2, and 3 days post-infusion. The secondary outcome was the proportion of participants with clinical response (≥50% reduction in MADRS scores) at 1, 2, and 3 days post-infusion. After all follow-up visits, participants were asked to guess which intervention they received.RESULTS Mean MADRS scores did not differ between groups at screening or pre-infusion baseline. The mixed-effects model showed no evidence of effect of group assignment on post-infusion MADRS scores at 1 to 3 days post-infusion (−5.82, 95% CI −13.3 to 1.64, p=0.13). Clinical response rates were similar between groups (60% versus 50% on day 1) and comparable to previous studies of ketamine in depressed populations. Secondary and exploratory outcomes did not find statistical separation of ketamine from placebo. 36.8% of participants guessed their treatment assignment correctly; both groups allocated their guesses in similar proportions. One serious adverse event occurred in each group, unrelated to ketamine administration.CONCLUSION In adults with major depressive disorder, a single dose of intravenous ketamine delivered during surgical anesthesia had no greater effect than placebo in acutely reducing the severity of depressive symptoms. This trial successfully masked treatment allocation in moderate-to-severely depressed patients using surgical anesthesia. While it is impractical to use surgical anesthesia for most placebo-controlled trials, future studies of novel antidepressants with acute psychoactive effects should make efforts to fully mask treatment assignment in order to minimize subject-expectancy bias. (ClinicalTrials.gov number, NCT03861988)Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03861988Funding StatementThis study received faculty start-up funding from the Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine. BDH received support for this trial from the Society for Neuroscience in Anesthesia and Critical Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of Stanford University gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesDe-identified participant data, data dictionaries, study protocol, and statistical analysis plan are available upon request after publication of the primary results manuscript in a peer-reviewed journal. To gain access to trial data for scientific research purposes, qualified researchers must submit a brief research proposal and statistical analysis plan for review and approval, and execute a data sharing agreement. Please direct all inquiries and requests to bheifets{at}stanford.edu.